Prof. Dr. Hartmut Juhl

Prof. Dr. Hartmut Juhl has a diverse work experience in the field of oncology. Prof. Dr. Hartmut began their career as a Wissenschaftlicher Mitarbeiter at UKE in 1987 and later worked as an Oberarzt at the Chirurgische Universitätsklinik Kiel until 1998. From 1998 to 2002, they served as an Associate Professor at the Georgetown Lombardi Comprehensive Cancer Center. Since 2002, Prof. Dr. Hartmut Juhl has been the CEO of Indivumed Group, a global oncology company specializing in biospecimen and clinical data collection and analysis.

Prof. Dr. Hartmut Juhl completed their higher education at the University of Hamburg, where they obtained a degree in Humanmedizin.